Discover whether AbbVie or Sanofi holds the edge in the global immunology market and find out which stock shows more ...

Sanofi's wide lineup of branded drugs and vaccines and robust pipeline create strong cash flows and a wide economic moat. Growth of existing products and new product launches should help offset ...

Japan’s Ministry of Health, Labour and Welfare in Japan has granted marketing and manufacturing authorization for Dupixent ...

Singaporean biotech Shanton Pharma has reported positive top-line results from a Phase IIb clinical trial of its ...

Xi meets with business reps as China takes aim at unilateralism and protectionism while ramping up a charm offensive for foreign investors against the backdrop of two global conferences In a ...